Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000991662 | SCV001143314 | benign | not provided | 2018-10-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000991662 | SCV001248628 | likely benign | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001326079 | SCV001517093 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002416272 | SCV002721763 | likely benign | Inborn genetic diseases | 2018-01-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |